cheaper semaglutide Indian drugmakers flood market with versions of Novo's Ozempic, Wegovy Obesity Drugs Are Getting Easier

Most patients achieve their desired results with a single treatment per area

The research supporting dual GIP and GLP-1 receptor agonism shows no time-of-day variation in receptor binding affinity or downstream metabolic effects

A network meta-analysis comparing the effects of glucose-lowering therapy on body weight and blood pressure indicates that the greatest efficacy for reducing body weight is seen with subcutaneous semaglutide followed by the other GLP-1 RA and SGLT2i, and the greatest reduction in blood pressure is seen with the SGLT2i and GLP-1 RA classes [224]

As the popularity of GLP-1 receptor agonists such as Ozempic, Wegovy, and Zepbound increases, a newly reported complication known as Ozempic feet has become a growing concern

Fatigue is classified as mild to moderate in the overwhelming majority of cases